Experts aren’t sure what the outcome of the DOJ’s recent lawsuit against the proposed UnitedHealth Group/Amedisys merger will be under the incoming Trump administration. The Biden administration has ...

Checkpoint inhibitors transformed cancer treatment, bringing to patients immunotherapies now widely used to treat a range of tumors. But there are different types of checkpoints that interact with ...

Several telehealth advocates are coming out in support of the Drug Enforcement Administration’s (DEA) third extension of Covid-19 telehealth flexibilities for the prescribing of controlled ...

Medicine stands at a remarkable crossroads. The explosive growth in specialty drug development marks a new golden age of therapeutic innovation. In 1990 there were just 10 specialty drugs on the ...

Keytruda, a Merck cancer immunotherapy that has become the world’s top-selling medication, is administered as an intravenous infusion over the course of 30 minutes. The pharmaceutical giant now ...

In a typical year, at least 1.7 million adults in America develop sepsis, a life-threatening response to infection. About 30% of severe sepsis patients don’t survive, and up to 50% of survivors ...

The rise of AI changes many spheres of life, with a projected growth rate of nearly 37% by 2030 — while healthcare is expected to see the most impact from AI use with a long-term adoption rate ...

Providers across the nation are continuing their work to make value-based care at scale a reality. One of the most recent examples of this comes from Emory Healthcare in Atlanta — on Monday, the ...

The overall market for specialty medications has grown dramatically over the past decade, and that trend is expected to continue for at least the next five years. Health systems, patients and ...

Vaginal discomfort is one of the most common reasons women seek healthcare advice, but standard care isn’t always meeting patients’ needs. That’s why Evvy, a vaginal microbiome startup, has ...

My grandfather was a World War II veteran and a Pearl Harbor survivor. While I was fortunate to hear some of his stories, Alzheimer’s robbed me of the chance to learn more about his remarkable ...